… explored lectin complement pathway activation in PLA2R-associated membranous
nephropathy (MN). … This study explored lectin complement pathway activation in PLA2R-associated …

… Membranous nephropathy (MN) is an immune kidney disease characterized by glomerular
subepithelial immune complexes (ICs) containing antigen, IgG, and products of complement …

… Membranous nephropathy (MN) is the major cause of adult … of primary glomerulonephritis
and end-stage renal disease (ESRD). … Therefore, membrane nephropathy may be improved by …

… nephropathy [Citation3,Citation4]. It is controversial whether this is a new type of membranous
nephropathy or an early form of secondary membranous nephropathy. From 2006 to 2015…

… Current approach to membranous nephropathy therapy and role of anti-PLA2R in monitoring
disease (2a). Therapeutic algorithm designed, adapted, and modified from figures 30 and …

… Research on membranous nephropathy truly exploded in the last 15 years. This happened
because of the application of new techniques (laser capture microdissection, mass …

… the frequency of idiopathic membranous nephropathy (IMN), which might ultimately predominate
over IgA nephropathy to become the leading type of primary glomerulopathy in the near …

… histopathologic features of membranous nephropathy. (A) … ‘primary’ membranous nephropathy.
This will be followed by antigens commonly encountered in membranous lupus nephritis, …

… Membranous nephropathy (MN) may occur in a kidney transplant as recurrence of the
original disease (rMN) or as a de novo MN (dnMN). rMN often occurs early, within the first year, …

… the complement activation and regulation systems, their physiological effects and roles in
maintenance of homeostasis in the host, and how dysregulation of the complement system …